RESUMEN
Dyslipidemia is an important risk factor in cardiovascular diseases. Different studies have shown that Apolipoprotein B [Apo B] is one of the best predictors in determining cardiovascular diseases and patients follow up after cardiovascular events. We hypothesized that there is a relation between Apo B levels and cardiovascular events in patients who have myocardial infarction [MI]. In addition, Apo B may be an appropriate marker for following these patients after MI. In this study, 220 patients with acute myocardial infarction were allocated at their admission to the hospital. They were followed for three months after MI and their morbidity and mortality rates were evaluated. Apo B levels were measured immunoturbidimetrically. Apo B levels were significantly higher in patients with the events including coronary artery bypass grafting [CABG], percutaneous coronary intervention [PCI] and malignant arrhythmias [P = 0.001]. Apo B levels can be an appropriate indicator of cardiovascular events in patients after MI.